PIK3CB Inhibitors Selectively Block the Survival of Glioblastoma Cells (P1.170)

Conclusions:Selective blockade of PIK3CB, but not other PI3K isoforms, is an effective therapy for glioblastoma with a low toxicity to normal tissues.Study Supported by:Virginia Tech Carilion School of MedicineVirginia Tech Carilion Research InstituteDisclosure: Dr. Le has nothing to disclose. Dr. Sheng has nothing to disclose.
Source: Neurology - Category: Neurology Authors: Tags: Neuro-oncology: Gliomas I Source Type: research